
cureVision
AI-powered optical system for chronic wound analysis.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $100k | Seed | |
Total Funding | 000k |
USD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | 157 % |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
cureVision is a German medical technology company founded in 2020 by Johannes Ruopp, Richard Fobo, and Kerstin von Diemar. The founders, two of whom are medical technology engineers, developed the initial prototype to address the inadequacies in traditional wound care, where analysis often relies on imprecise tools like paper rulers. The company is headquartered in Munich, Germany.
The firm has developed an MDR-approved, all-in-one hardware and software system for the analysis of chronic wounds. The handheld device utilizes optical sensors and computer vision to perform a 3D measurement of a wound's length, width, and depth, conduct tissue analysis, and document other healing parameters. This automated process is designed to be 90% faster than manual methods, generating a detailed wound report in about two minutes with 98% accuracy. The system aims to provide a more objective and reliable basis for treatment decisions compared to traditional subjective assessments. A web-based platform, cureVision® Web, allows for the central management of patient data, editing of wound reports, and tracking healing progress over time.
cureVision operates on a B2B business model, targeting hospitals, nursing homes, outpatient care facilities, and home care services. The technology provides clients with significant time savings in documentation and a higher quality of care through precise and consistent data. The company has received funding from investors including Luminate, the European Union, AQAL Group, Angels4Health, and EIT Health. cureVision has also won several awards, such as the Health-i Award from Techniker Krankenkasse and Handelsblatt in 2023.
Keywords: chronic wound care, wound documentation, medical imaging, computer vision, 3D wound measurement, telemedical assessment, tissue analysis, digital health, MedTech, healthcare IT, wound analysis system, optical sensors, AI in healthcare, remote patient monitoring, clinical decision support, wound management, digital wound report, medical device, automated assessment, healthcare efficiency